38 results
424B5
BLPH
Bellerophon Therapeutics, Inc.
31 May 23
Prospectus supplement for primary offering
4:40pm
; or
agree or otherwise commit to do any of the foregoing (unless the commitment is conditioned on obtaining the approval of the New Mountain Entities … there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether stockholders are entitled to oversubscription
424B5
BLPH
Bellerophon Therapeutics, Inc.
17 Jul 20
Prospectus supplement for primary offering
5:01pm
officer; or
agree or otherwise commit to do any of the foregoing (unless the commitment is conditioned on obtaining the approval of the New Mountain … backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether stockholders are entitled to oversubscription rights, if any
8-K
EX-10.1
k61ot1nh0toz7rd
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-4.1
4feuk4v42sxj 1qei
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
424B5
20zfpck7 dys5cujm59
20 May 20
Prospectus supplement for primary offering
4:03pm
424B5
ny0fby1t
20 May 20
Prospectus supplement for primary offering
4:02pm
424B5
f0n h8eq9w7qsoad
18 May 20
Prospectus supplement for primary offering
4:02pm
424B5
lvjgy
31 Mar 20
Prospectus supplement for primary offering
7:03am
8-K
EX-1.1
1u3ks20v vm
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
8-K
EX-10.1
n9wj5mj6qukmmeusqons
17 Dec 19
Statistically Significant Improvement Demonstrated in Moderate to Vigorous Physical Activity
8:24am
424B5
xb30dba
23 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
mr6giuicnwa2azop0d
23 Jan 19
Prospectus supplement for primary offering
12:00am